Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Observational Study to Describe the Treatment Situation of Chinese County Population With HER2+ & HR+/HER2- Breast Cancer

NCT05544123 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Xinxiang Medical College as lead sponsor.

NCT NCT05544123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05544123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Observational Study to Describe the Treatment Situation of Chinese County Population With HER2+ & HR+/HER2- Breast Cancer
Lead sponsor
The First Affiliated Hospital of Xinxiang Medical College
Phase
Observational
Overall status
Unknown status
Start date
September 29, 2022
Completion date
September 30, 2024
Enrollment
2,500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast carcinoma, breast tumor